<delect id="btvt5"></delect>

        <thead id="btvt5"><video id="btvt5"><output id="btvt5"></output></video></thead>

        <track id="btvt5"></track>



          its market to more than 30 provinces and cities


          over 500 tertiary hospitals


          over 1,000 communities and secondary hospitals


          turnover of exceeding RMB 500 million

          Pharmaceutical sales service

                 As a wholly-owned subsidiary of Huawei Pharmaceutical Group Co., Ltd., Beijing Huawei Medical LLC is responsible for the sales and market of medical products. With a hard-working sales team of outstanding expertise and marketing experience, the Company has expanded its market to more than 30 provinces and cities, including over 500 tertiary hospitals and over 1,000 communities and secondary hospitals and promoted its products of pediatrics, pneumology, oncology, hematology, gynecology, orthopedics, hepatology and gastroenterology internal medicine with an annual turnover of exceeding RMB 500 million. Meanwhile, the Company has established long-term strategic partnerships with plenty of pharmaceutical companies. Its operation philosophy is “win-win cooperation”, “providing excellent service” and “serving as a good partner”.

          Development of new product and technology

                 Huawei Pharmaceutical Development and Consulting (Beijing) Co., Ltd. is a wholly-owned subsidiary of Huawei Pharmaceutical Group Co., Ltd. Targeting at medical programs failing to meet patients' demands and with the Medical Excellence Japan (MEJ) as a strategic partner, the company is developing world-leading medical products and introducing globally advanced medical programs for the benefit of people's health, based on cooperation in medical products developed by Japan. Now, we have introduced Cefcapene Pivoxil Hydrochloride Granules from Japan’s Shionogi Inc.

                 Since 2017, we have carried out multiple exchanges and cooperation with PMDA, MEJ, Japanese Medical Association, etc.


          Introduction and development of pharmaceutical products
          Introduction and development of pharmaceutical products

          We cooperate with Japanese pharmaceutical and medical device companies to develop businesses and establish projects of pharmaceutical products introduced.

          Registration of pharmaceutical products
          Registration of pharmaceutical products

          In addition to self-developed products, we serve as an agent for pharmaceutical products of domestic and foreign companies, develop products and register them for marketing.

          Clinical research
          Clinical research

          We implement clinical research of pharmaceutical products to support domestic and foreign pharmaceutical companies.

          Policy consulting
          Policy consulting

          We help domestic and foreign pharmaceutical companies connect with the pharmaceutical regulatory authority and implement policy consulting activities on product development, registration and so on.

          Product Investment
          Product Investment

          We assist pharmaceutical companies in China and Japan to conduct investment, cooperation and joint research and development of new products in the frontier of pharmaceutical innovation.

          Mobile phone


          ADD:2812/2815/2816/2817, Nanyin building, No. 2, East Third Ring North Road, Chaoyang District, Beijing

          Copyright(C)2022,Huawei Pharmaceutical Group All Rights Reserved.
           Supported by Toocle 31fabu Copyright Notice